Advertisement
MTD vs SYK
Which Stock Would AI Choose? Mettler-Toledo International (MTD) vs. Stryker Corporation (SYK) Stock Comparison
Key Takeaways
- MTD is a precision-instruments leader benefiting from recovering demand in China and emerging markets, while SYK is a diversified medical-technology firm rebounding from an early-year cybersecurity disruption.
- Both companies recently beat earnings estimates, but their share-price reactions diverged, reflecting different sentiment dynamics.
- MTD raised its full-year outlook and expanded a share-buyback program, while SYK narrowed its guidance, prompting a post-earnings pullback despite strong growth.
- Relative performance and market positioning differ sharply: MTD is a mid-cap cyclical instrument maker, whereas SYK is a large-cap healthcare growth compounder.
- Risk profiles vary: MTD faces tariff and trade sensitivity, while SYK carries execution and integration risks tied to its product pipeline.
Introduction
This stock comparison examines two names that rarely sit in the same portfolio bucket: MTD, a global supplier of precision weighing and analytical instruments, and SYK, one of the world's largest medical-device makers. Although both operate in technology-driven industries and serve large installed bases, their growth drivers, sector exposure, and investor sentiment follow different paths. For traders and investors weighing a cyclical, cash-generative industrial franchise against a diversified healthcare growth platform, understanding their relative performance and market positioning can clarify which profile fits a given strategy under current conditions.
MTD Overview and Recent Performance
Mettler-Toledo International Inc. (MTD) designs and services precision instruments used in laboratory, industrial, and food-retail settings, including balances, analytical instruments, and inspection systems. In recent weeks the company reported second-quarter results that showed adjusted earnings rising 14% year over year, supported by a 9% gain in China and high-single-digit growth in other emerging markets. The company raised its full-year 2026 local-currency sales growth outlook to approximately 4–5% and lifted its adjusted EPS (earnings per share) guidance, while announcing an increased $875 million share-repurchase plan.
This positive fundamental backdrop has coincided with a notable rise in the share price over recent months, with sentiment improving as biopharma, automation, semiconductor, battery, and food-manufacturing demand strengthened. Still, the stock carries regional risks, particularly around tariffs, trade friction, and softer equipment-replacement cycles in Europe and China, which analysts continue to monitor.
SYK Overview and Recent Performance
Stryker Corporation (SYK) is a leading medical-technology company with three reporting segments: MedSurg and Neurotechnology, and Orthopaedics. Its products span surgical equipment, implants, neurotechnology, and the Mako robotic-assisted surgery platform. Recent market activity has been shaped by recovery from a first-quarter cybersecurity incident that temporarily disrupted production and shipments. In its latest quarter, revenue rose 9.4% to $6.59 billion and adjusted EPS climbed 17.9% year over year, as plants returned to normal operation and capital-order deliveries accelerated.
Despite the earnings beat, shares pulled back after the company narrowed, rather than raised, its full-year organic sales and adjusted EPS guidance. This reaction highlights how execution concerns—cyber-remediation costs, vascular supply constraints, and the pace of new product ramps—can temper an otherwise strong fundamental story. Demand across the portfolio remains broad, and record Mako installations continue to support the robotics franchise.
Trending AI Robots
For investors seeking a data-driven edge, Tickeron's Trending AI Robots page showcases a curated selection of automated trading strategies. Tickeron operates hundreds of AI Trading Bots that trade thousands of different tickers, each with its own trading style, strategy, timeframe, performance history, and set of covered symbols. Because not every bot suits every market regime, the Trending AI Robots section highlights only those models considered most appropriate for current conditions, based on their recent statistics and consistency. Whether you are comparing large-cap healthcare names or cyclical industrial stocks, exploring these tools can offer a systematic complement to fundamental analysis. Visit the Trending AI Robots page to review the latest featured strategies.
Head-to-Head Comparison
The two companies differ most clearly in business model and growth profile. MTD is a mid-cap, hardware-and-service business whose results track laboratory and industrial capital spending cycles, giving it meaningful sensitivity to regional macro conditions and trade policy. SYK, by contrast, is a large-cap healthcare franchise driven by procedural volumes, aging demographics, and adoption of robotic-assisted surgery, factors that tend to be less correlated with short-term economic swings.
On recent momentum, MTD has shown stronger relative performance, with its raised guidance and buyback supporting an upward share-price trend. SYK delivered faster top- and bottom-line growth in percentage terms, yet its narrowed guidance and execution overhang weighed on sentiment, producing a post-earnings decline. Valuation also contrasts: SYK trades at a premium to its industry but below its own five-year historical median, while MTD trades near or modestly above analyst fair-value estimates. Risk factors diverge accordingly, with tariff and demand-cycle exposure on one side and integration, supply, and product-launch execution on the other.
Tickeron AI Verdict
Based on observable trend consistency, relative positioning, and near-term catalysts, Tickeron's AI framework would likely favor MTD in the current environment. The company's upward earnings revisions, expanding buyback, and improving emerging-market demand suggest a more consistent positive momentum profile, whereas SYK currently faces sentiment headwinds tied to guidance and execution even as its underlying growth remains robust. This assessment is probabilistic rather than definitive: a sustained re-acceleration of SYK's capital-equipment deliveries and a smoother product ramp could shift the relative picture over the coming months.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a Buy and SYK is a Buy.
MTD | SYK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 59 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 7 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 94 | |
SMR RATING 1..100 | 3 | 52 | |
PRICE GROWTH RATING 1..100 | 38 | 64 | |
P/E GROWTH RATING 1..100 | 28 | 86 | |
SEASONALITY SCORE 1..100 | 75 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SYK's Valuation (7) in the Medical Specialties industry is significantly better than the same rating for MTD (99). This means that SYK’s stock grew significantly faster than MTD’s over the last 12 months.
SYK's Profit vs Risk Rating (94) in the Medical Specialties industry is in the same range as MTD (100). This means that SYK’s stock grew similarly to MTD’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for SYK (52). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
MTD's Price Growth Rating (38) in the Medical Specialties industry is in the same range as SYK (64). This means that MTD’s stock grew similarly to SYK’s over the last 12 months.
MTD's P/E Growth Rating (28) in the Medical Specialties industry is somewhat better than the same rating for SYK (86). This means that MTD’s stock grew somewhat faster than SYK’s over the last 12 months.
| MTD | SYK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 83% |
| Stochastic ODDS (%) | 2 days ago 62% | 2 days ago 65% |
| Momentum ODDS (%) | 2 days ago 68% | N/A |
| MACD ODDS (%) | 2 days ago 63% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 65% | 2 days ago 55% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 53% |
| Advances ODDS (%) | 9 days ago 62% | 4 days ago 57% |
| Declines ODDS (%) | 2 days ago 66% | 2 days ago 51% |
| BollingerBands ODDS (%) | 2 days ago 58% | 2 days ago 70% |
| Aroon ODDS (%) | 2 days ago 66% | 2 days ago 48% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTD’s FA Score shows that 2 FA rating(s) are green while SYK’s FA Score has 1 green FA rating(s).
- MTD’s FA Score: 2 green, 3 red.
- SYK’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTD’s TA Score shows that 5 TA indicator(s) are bullish while SYK’s TA Score has 5 bullish TA indicator(s).
- MTD’s TA Score: 5 bullish, 5 bearish.
- SYK’s TA Score: 5 bullish, 4 bearish.
Price Growth
MTD (@Medical Specialties) experienced а -2.50% price change this week, while SYK (@Medical/Nursing Services) price change was +1.51% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -2.80%. For the same industry, the average monthly price growth was +3.90%, and the average quarterly price growth was +46.85%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.19%. For the same industry, the average monthly price growth was -6.00%, and the average quarterly price growth was -2.76%.
Reported Earning Dates
MTD is expected to report earnings on Nov 05, 2026.
SYK is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical Specialties (-2.80% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.19% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
SYK and
Correlation & Price change
A.I.dvisor indicates that over the last year, SYK has been loosely correlated with ISRG. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if SYK jumps, then ISRG could also see price increases.